Procter & Gamble (PG)

The support comes in right at about $73, and it hasn’t been broken. If you own, and you’ve held up for this long, you might want to continue holding it. It has tested around $72 over and over and over, and not failed. As a new buyer, he would only buy it if it bounced off of the support line.

This is a consumer staple stock which normally does okay at this time of year. Consumer staple stocks are the best performing sector from May to October. It doesn’t mean that they go up a lot, just that they go down less then the rest of the market. Technicals are not so good. It is in a downward trend, underperforming the market, below its 20 day moving average and as yet has shown no signs of bottoming. Getting very close to its support level, so your downside risk is probably minimal. However, your upside potential is not the greatest.

Had a really tough time. 2/3rds of sales are outside of the US. You have a decent yield, but not sure you are getting paid enough for their growth. It may be an opportunity to buy into it.

Share price has been quite weak with the move upwards in the US$. They have significant businesses outside of the US. However, when you have a temporary move and divergence in currencies in a short period of time, it can create opportunities to buy very high quality companies, at a slightly depressed price. Trading at about 20 X earnings, so not cheap. If it pulls back a lot from where it is, it would be a pretty good buying opportunity. 3% dividend yield.

This has a very specific seasonal trend. It tends to do well from Aug 17 to Nov 19. It is a consumer staples stock, which tends to do well in that time frame period, when they’re transitioning out of the weaker summer months into the stronger winter months. This has done well, up until this point, but right now we are past that seasonal period. He would wait.

Not cheap. Doesn't think you're going to shoot the lights out on growth, but it has a good yield, and over the long-term, could think of worse things to own.

Best in breed, but it is a developed economy story. It is US centric and Canada centric. You buy this and put it away and give it to your grandkids. Also, gradually increases its dividend. Because of the decline in emerging market currencies, Unilever (UL-N) might be a better value option at this time.

The whole category of consumer staples stocks has had a tremendous run in the 1^st half of the year. This has started to give back in the last little while. Not crazy about the valuation here, but in the staples group, this would be one of the ones that he would like.

Defensive name. A high quality company within that sector. Steady dividend. They have exposure to emerging markets. A decent holding, but she has not made the move. She would if it pulled back.

Fairly decent potential. Looking at his FMV calculation, it could actually reach up to $95. Lately the earnings forecasts have been ticking up a little bit, which might encourage the stock to get a little bit further. However, if it gets to $95, don’t forget to take your profits and get out.

Growth is still relatively strong, but the valuation is rather high. This one was considered safer growth. It is not particularly cheap. They will have to start doing acquisitions again to get growth. It is a problem for the consumer sector in general. He has no exposure to consumer retail / discretionary.

Great company and one that has excelled over the years, but trading at around 18X earnings right now. The consumer packaged space is really a slow growth space. If they can get 2%-3% revenue growth, they are happy. It just doesn’t support an 18 multiple. A lot of money has flowed into this because of an attractive dividend, but he would be a little bit concerned with the capital given the multiple and where it is.

Prefers UL-N and MDLZ-Q.

It hit her radar in terms of valuation where she would consider taking a position. A great brand that is struggling a bit because of their emerging market exposure. A temporary setback. Doesn’t think you will get hurt.

The premier consumer product company. Good quality product. Exposed to the global market. Has been somewhat slow growing for the last few years. Organically their basically looking at low single digit growth. With cost-cutting and stock buyback, they may be able to get a 5%-8% upside per year, which he doesn’t think is enough for most portfolios. Longer-term, he doesn’t see anything wrong with it.